Changchun BCHT Biotechnology Co. (SHA:688276)

China flag China · Delayed Price · Currency is CNY
20.10
+0.20 (1.01%)
At close: Feb 3, 2026
-9.50%
Market Cap8.31B -16.9%
Revenue (ttm)677.51M -57.9%
Net Income-170.53M
EPS-0.41
Shares Out413.66M
PE Ration/a
Forward PE10.63
Dividend0.17 (0.85%)
Ex-Dividend DateJun 18, 2025
Volume2,421,857
Average Volume4,368,313
Open20.02
Previous Close19.90
Day's Range19.80 - 20.13
52-Week Range18.83 - 26.30
Beta-0.01
RSI44.85
Earnings DateMar 12, 2026

About SHA:688276

Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally. The company’s products include herpes zoster vaccine; varicella vaccine; live, nasal, and freeze-dried influenza vaccine; and rabies vaccine (vero cell) for humans. Changchun BCHT Biotechnology Co. Ltd. was founded in 2004 and is based in Changchun, China. [Read more]

Sector Healthcare
Founded 2004
Employees 1,266
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688276
Full Company Profile

Financial Performance

In 2024, SHA:688276's revenue was 1.23 billion, a decrease of -32.64% compared to the previous year's 1.82 billion. Earnings were 232.09 million, a decrease of -53.67%.

Financial Statements